This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Almirall enters into a definitive agreement to divest ThermiGen, its medical device aesthetics business
Almirall S.A. (ALM) announced that it has entered into a definitive agreement with Celling Biosciences, based in Austin (Texas), to divest ThermiGen for an undisclosed amount. The transaction is expected to close before or